Position in TNGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$207,231,823
+$181,825,349 QoQ
Shares Held
9,905,919
+245.4% QoQ
Ownership
6.85%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 99.94737489777576.ToString("F0")%
Shared 0.ToString("F0")%
None 0.05262510222423583.ToString("F0")%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. TNGX ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in TNGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $207,231,823 | 9,905,919 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,406,474 | 2,867,548 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $53,978 | 6,426 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,559 | 5,578 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,716 | 10,742 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $27,306 | 8,837 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $72,224,435 | 9,379,797 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $80,729,888 | 9,409,078 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $75,363,739 | 9,491,655 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $96,894,764 | 9,787,350 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $131,131,042 | 11,645,741 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $34,424,401 | 10,368,796 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $37,560,268 | 9,508,929 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $65,856,672 | 9,083,679 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $25,478,790 | 7,038,340 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $34,572,583 | 7,631,917 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $52,119,889 | 6,875,975 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $78,573,135 | 7,182,188 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $80,837,234 | 6,251,913 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||